R

Recursion

1001-5000 employees· United States·Website ↗

Biotech company combining AI, automation, and wet lab biology to discover and develop drugs at industrial scale.

Biotechnology
Share:
Get the full context.

Sign up to read complete case studies, access detailed metrics, and unlock all use cases.

Use Cases (1)

R
Recursion
40%
wet lab work reduction for equivalent value

Recursion and MIT’s Jameel Clinic partnered to develop Boltz-2, an open-source biomolecular foundation model trained on NVIDIA’s BioHive-2 supercomputer that simultaneously predicts protein complex structures and binding affinities. The model ranked first on CASP16 affinity data, delivers results in ~20 GPU-seconds per ligand-protein pair, and achieves up to 3x inference speedup via NVIDIA NIM — enabling drug discovery teams to get 80% of experimental value with 40% less wet lab work.

BiotechnologyNNNVIDIA NIM
Recursion AI Use Cases & Strategy | Applied